Shanghai Yizhong Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Shanghai Yizhong Pharmaceutical Co Ltd cash flow reinvestment rate. Shanghai Yizhong Pharmaceutical Co Ltd (688091) has a Cash Flow Reinvestment Rate of 1.44x as of September 2025, reinvesting CN¥30.36 Million (capex CN¥30.36 Million ) from operating cash flow of CN¥21.03 Million. See Shanghai Yizhong Pharmaceutical Co Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Shanghai Yizhong Pharmaceutical Co Ltd (2022–2024)
Cash flow reinvestment rate of Shanghai Yizhong Pharmaceutical Co Ltd from 2022 to 2024. Historical reinvestment intensity for Shanghai Yizhong Pharmaceutical Co Ltd across 3 annual periods. Explore Shanghai Yizhong Pharmaceutical Co Ltd (688091) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Shanghai Yizhong Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2022–2024)
Shanghai Yizhong Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2022 to 2024. Year-by-year capital reinvestment analysis for Shanghai Yizhong Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 688091 cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.60x | CN¥102.42 Million | CN¥39.44 Million | CN¥80.04 Million | ▲ +367.8% |
| 2023 | 0.56x | CN¥48.06 Million | CN¥86.55 Million | CN¥8.78 Million | ▼ -88.6% |
| 2022 | 4.86x | CN¥538.15 Million | CN¥110.78 Million | CN¥35.88 Million | — |